Vanguard Personalized Indexing Management
LAB icon

Vanguard Personalized Indexing Management’s Standard BioTools LAB Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,425
Closed -$9.58K – 2298
2026
Q1 		$9.58K Sell
10,425
-6,200
-37% -$7.5K ﹤0.01% 2155
2025
Q4 		$21.3K Sell
16,625
-216
-1% -$290 ﹤0.01% 1936
2025
Q3 		$21.9K Buy
16,841
+1,155
+7% +$1.51K ﹤0.01% 1961
2025
Q2 		$18.8K Buy
+15,686
New +$17.4K ﹤0.01% 1910
2024
Q3 		– Sell
-11,033
Closed -$19.5K – 1801
2024
Q2 		$19.5K Buy
+11,033
New +$27K ﹤0.01% 1653

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Personalized Indexing Management's LAB Position: Q2 2026 in Review

Vanguard Personalized Indexing Management sold out of Standard BioTools (LAB) in Q2 2026, closing a stake of 10,425 shares — an estimated $9.58K sold.

Vanguard Personalized Indexing Management first reported a position in LAB in Q2 2024 and held it in 5 quarters. The position peaked at $21.9K in Q3 2025. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Vanguard Personalized Indexing Management reported no remaining Standard BioTools position as of Q2 2026 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 10,425 Standard BioTools shares in Q2 2026, an estimated $9.58K.
  • Vanguard Personalized Indexing Management first reported a position in Standard BioTools in Q2 2024 and held it in 5 quarters.
  • Vanguard Personalized Indexing Management's Standard BioTools position peaked at $21.9K in Q3 2025.
  • 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.